These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 6398545
41. Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation. Massardo L, Metz C, Pardo E, Mezzano V, Babul M, Jarpa E, Guzmán AM, André S, Kaltner H, Gabius HJ, Jacobelli S, González A, Soza A. Lupus; 2009 May; 18(6):539-46. PubMed ID: 19395456 [Abstract] [Full Text] [Related]
43. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity. Vangelista A, Frascà GM, Nanni-Costa A, Bonomini V. Trans Am Soc Artif Intern Organs; 1983 May; 29():749-53. PubMed ID: 6608818 [No Abstract] [Full Text] [Related]
44. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. Lee YH, Kim YR, Ji JD, Sohn J, Song GG. J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967 [Abstract] [Full Text] [Related]
45. [Various immunological and clinical aspects of juvenile chronic arthritis and systemic lupus erythematosus in children]. Romicka AM, Rostropowicz-Denisiewicz K, Swierczyńska Z, Luft S, Kosowska E, Wierzchowska E. Pediatr Pol; 1986 Apr; 61(4):201-9. PubMed ID: 3797147 [No Abstract] [Full Text] [Related]
46. [Immunological reactions to connective tissue antigens in rheumatoid arthritis, systemic scleroderma and systemic lupus erythematosus]. Abdeeva ZhI, Zakharova MM, Rassokhina II, Trofimova TM, Samoĭlova SI. Ter Arkh; 1980 Apr; 52(11):122-6. PubMed ID: 7466639 [No Abstract] [Full Text] [Related]
47. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. Schneider M, Berning T, Waldendorf M, Glaser J, Gerlach U. J Rheumatol; 1990 Jul; 17(7):900-7. PubMed ID: 2213756 [Abstract] [Full Text] [Related]
48. [Use of levamisole in the adjuvant therapy of rheumatoid arthritis and systemic lupus erythematosus]. Gandzha IM, Sakharchuk VM, Lysenko GI, Mironova KA, Galetskaia TM. Vrach Delo; 1981 Feb; (2):16-8. PubMed ID: 7222600 [No Abstract] [Full Text] [Related]
52. [Clinical significance of serial measurement of immune complexes in the management of SLE (author's transl)]. Sakurai T, Kono I, Kabashima T, Yamane K, Kashiwagi H. Ryumachi; 1980 Sep; 20(4):247-52. PubMed ID: 7444662 [No Abstract] [Full Text] [Related]
53. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, Takasaki Y. Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420 [Abstract] [Full Text] [Related]
55. [Lymphoplasmapheresis in the treatment of rheumatoid arthritis]. Di Matteo L, Quaglietta AD, Incecco V, Dragani A, Iacone A, Consoli G. Boll Soc Ital Biol Sper; 1985 Jun 30; 61(6):883-90. PubMed ID: 4052254 [No Abstract] [Full Text] [Related]
56. Association of Fc gamma receptor IIIB, but not of Fc gamma receptor IIA and IIIA polymorphisms with systemic lupus erythematosus in Japanese. Hatta Y, Tsuchiya N, Ohashi J, Matsushita M, Fujiwara K, Hagiwara K, Juji T, Tokunaga K. Genes Immun; 1999 Sep 30; 1(1):53-60. PubMed ID: 11197306 [Abstract] [Full Text] [Related]